Q3 EPS Estimates for CG Oncology Lowered by HC Wainwright

Дата публикации: 10-08-2026 05:28:54

CG Oncology, Inc. (NASDAQ:CGON – Free Report) – Equities research analysts at HC Wainwright cut their Q3 2026 EPS estimates for CG Oncology in a note issued to investors on Thursday, August 6th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings per share of ($0.96) for the quarter, down from […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FY2026 EPS Estimates for Galiano Gold Lowered by Analyst	0	12.64	10-08-2026
2	What is HC Wainwright’s Estimate for PTGX FY2026 Earnings?	0	13.4	10-08-2026
3	HC Wainwright Reduces Earnings Estimates for Galiano Gold	0	10.78	10-08-2026
4	Research Analysts Offer Predictions for CMPX Q3 Earnings	0	11.48	10-08-2026
5	What is HC Wainwright’s Forecast for Biodesix Q3 Earnings?	0	12.55	10-08-2026
6	HC Wainwright Expects Reduced Earnings for Alto Ingredients	0	10.44	10-08-2026
7	Energy Fuels FY2026 EPS Estimate Reduced by HC Wainwright	0	13.4	10-08-2026
8	Analysts Issue Forecasts for Energy Fuels FY2026 Earnings	0	13.04	10-08-2026
9	HC Wainwright Issues Pessimistic Outlook for SABS Earnings	0	12.58	10-08-2026
10	FY2026 EPS Estimates for Fuel Tech Decreased by Analyst	0	12.27	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.48. Источник: www.americanbankingnews.com.